{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:46:33Z","timestamp":1717595193103},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.transci.2005.06.001","type":"journal-article","created":{"date-parts":[[2005,9,3]],"date-time":"2005-09-03T11:14:26Z","timestamp":1125746066000},"page":"191-197","source":"Crossref","is-referenced-by-count":5,"title":["What\u2019s happening? The expanding role of apheresis platelet support in neonatal alloimmune thrombocytopenia: Current status and future trends"],"prefix":"10.1016","volume":"33","author":[{"given":"Hagop","family":"Bessos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerard","family":"Seghatchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2005.06.001_bib1","series-title":"Platelet therapy: current status and future trends","year":"2000"},{"key":"10.1016\/j.transci.2005.06.001_bib2","unstructured":"Turner M, Bessos H, et al. Prospective epidemiological study of the outcome and cost effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia (NAIT) due to anti-HPA-1a. Transfusion, in press."},{"key":"10.1016\/j.transci.2005.06.001_bib3","unstructured":"Seghatchian J. Platelet storage lesion: the influence of various leukoreduction procedures on generation\/retention of some biological response modifiers, microvesiculation, distribution of membrane-bound\/soluble Prion and the rate of HLA-CLASS1 release. Trans Apher Sci, in press."},{"key":"10.1016\/j.transci.2005.06.001_bib4","series-title":"Bailliere\u2019s clinical haematology: international practice and research","first-page":"391","article-title":"The fetal and neonatal consequences of maternal alloimmune thrombocytopenia","author":"Bussel","year":"1998"},{"issue":"3","key":"10.1016\/j.transci.2005.06.001_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2000.0083","article-title":"The management of alloimmune neonatal thrombocytopenia","volume":"13","author":"Blanchette","year":"2000","journal-title":"Bailliere\u2019s Clin Haematol"},{"key":"10.1016\/j.transci.2005.06.001_bib6","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunisation to the platelet-specific antigen HPA-1a as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transci.2005.06.001_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-3148.1992.tb00168.x","article-title":"Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy","volume":"2","author":"Kaplan","year":"1992","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2005.06.001_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 cases of suspected neonatal alloimmune thrombocytopenia","volume":"1","author":"Mueller-Eckhardt","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2005.06.001_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1991.tb04459.x","article-title":"HPA-5b (Bra) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases","volume":"789","author":"Kaplan","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2005.06.001_bib10","doi-asserted-by":"crossref","unstructured":"Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. The Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004226.pub2. doi:10.1002\/14651858.CD004226.pub2.","DOI":"10.1002\/14651858.CD004226.pub2"},{"key":"10.1016\/j.transci.2005.06.001_bib11","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomised trial of the addition of low dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obs Gyn"},{"key":"10.1016\/j.transci.2005.06.001_bib12","unstructured":"Marc T, Bessos H, Fagge T, et al. Prospective epidemiological study of the outcome and cost effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia (NAIT) due to anti-HPA-1a. Transfusion, in press."},{"key":"10.1016\/j.transci.2005.06.001_bib13","series-title":"Platelet therapy: current status and future trends","first-page":"504","article-title":"Immunomodulatory aspects","author":"Brand","year":"2000"},{"key":"10.1016\/j.transci.2005.06.001_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1473-0502(03)00112-5","article-title":"Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned","volume":"29","author":"Seghatchian","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2005.06.001_bib15","first-page":"428","article-title":"Perspectives in platelet transfusion: evolving alternative therapeutic products","volume":"8","author":"Bessos","year":"1997","journal-title":"Platelets"},{"key":"10.1016\/j.transci.2005.06.001_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0955-3886(00)00006-0","article-title":"Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characterisation of the red cell and platelet concentrates and the clinical responses to transfusion","volume":"22","author":"Murphy","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.transci.2005.06.001_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.2000.40010091.x","article-title":"Preparation and storage of characteristics of white blood cell-reduced high-concentration of platelet concentrates collected by apheresis system for transfusion in utero","volume":"40","author":"Dumont","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2005.06.001_bib18_1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1196\/annals.1299.100","article-title":"Blood cells apoptosis\/necrosis: some clinical and laboratory aspects","volume":"1010","author":"Seghatchian","year":"2003","journal-title":"Ann NY Acad"},{"key":"10.1016\/j.transci.2005.06.001_bib18_2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1046\/j.1537-2995.2002.00175.x","article-title":"Apoptosis, transforming growth factor beta and the immunosuppressive effect of transfusion","volume":"42","author":"Dzick","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2005.06.001_bib19","unstructured":"Norfolk D. Ultraviolet and gamma irradiated platelets: in vitro and in vivo response. In: Seghatchian J, Snyder El, Krailadsiri P, editors. Platelet therapy. Amsterdam, The Netherlands, 2000. p. 416\u201333 [Chapter 10]."},{"key":"10.1016\/j.transci.2005.06.001_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0955-3886(00)00035-7","article-title":"Does bacteria contamination of platelet concentrates influences the leucocytes content and the rate of platelet storage lesion","volume":"22","author":"Seghatchian","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.transci.2005.06.001_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1423-0410.2000.7830171.x","article-title":"Are leucodepleted platelet concentrates equivalent? Comparison of cobe LRS Turbo, Haemonetics MCS+ LD and filtered pooled buffy- coat-derived platelets","volume":"78","author":"Krailadsiri","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2005.06.001_bib22","doi-asserted-by":"crossref","first-page":"F173","DOI":"10.1136\/fn.82.3.F173","article-title":"Management of severe alloimmune thrombocytopenia in the newborn","volume":"82","author":"Ouwehand","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.transci.2005.06.001_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1423-0410.2003.00327.x","article-title":"Report on the eleventh international society of blood transfusion platelet genotyping and serology workshop","volume":"85","author":"Goldman","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2005.06.001_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.21307\/immunohematology-2019-617","article-title":"Provision of HPA-1a (PlA1)-negative platelets for neonatal alloimmune thrombocytopenia: screening, testing, and transfusion protocol","volume":"15","author":"Munizza","year":"1999","journal-title":"Immunohaematology"},{"key":"10.1016\/j.transci.2005.06.001_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1423-0410.1999.7720103.x","article-title":"An international trial demonstrates suitability of a newly developed whole-blood ELISA kit for multicentre platelet HPA-1 phenotyping","volume":"77","author":"Bessos","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2005.06.001_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2141.2001.02703.x","article-title":"Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia","volume":"113","author":"Ranasingh","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2005.06.001_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-3148.2004.00536.x","article-title":"Survey of the use and clinical effectiveness of HPA-1a\/5b-negative platelet concentrates in proven or suspected platelet alloimmunisation","volume":"14","author":"Allen","year":"2004","journal-title":"Transfus Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050205001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050205001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:55:50Z","timestamp":1626479750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050205001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1473050205001242"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2005.06.001","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}